Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Regules

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Scientific Reports|August 13, 2017
Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosisSidhartha Chaudhury, Jason A Regules, Christian A Darko, et al.
Journal of Clinical Medicine|April 12, 2022
Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against <i>Plasmodium</i> and <i>Anopheles</i> AntigensSidhartha Chaudhury, Jessica S Bolton, Leigh Anne Eller, et al.
Infection and Immunity|December 19, 2018
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic AntigensCysha E Hall, Lisa M Hagan, Elke Bergmann-Leitner, et al.
American Journal of Infection Control|September 30, 2004
The effect of semipermeable dressings on smallpox vaccine site evolutionJason A Regules, David P Dooley, Matthew J Hepburn, et al.
NPJ Vaccines|January 28, 2022
Restricted valency (NPNA)<sub>n</sub> repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparumMark D Langowski, Farhat A Khan, Sofya Savransky, et al.
Plos One|June 3, 2021
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platformSidhartha Chaudhury, Jack Hutter, Jessica S Bolton, et al.
The Journal of Infectious Diseases|August 19, 2025
Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protectionDeAnna J Friedman-Klabanoff, Travis L Jensen, Casey E Gelber, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trialMichael W Ellis, Matthew E Griffith, David P Dooley, et al.
Vaccine|October 1, 2021
A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01<sub>E</sub> in a controlled human malaria infection challengeJames E Moon, Melissa E Greenleaf, Jason A Regules, et al.
The Journal of Infectious Diseases|July 21, 2020
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive AdultsJames E Moon, Christian Ockenhouse, Jason A Regules, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Scientific Reports|August 13, 2017
Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosisSidhartha Chaudhury, Jason A Regules, Christian A Darko, et al.
Journal of Clinical Medicine|April 12, 2022
Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against <i>Plasmodium</i> and <i>Anopheles</i> AntigensSidhartha Chaudhury, Jessica S Bolton, Leigh Anne Eller, et al.
Infection and Immunity|December 19, 2018
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic AntigensCysha E Hall, Lisa M Hagan, Elke Bergmann-Leitner, et al.
American Journal of Infection Control|September 30, 2004
The effect of semipermeable dressings on smallpox vaccine site evolutionJason A Regules, David P Dooley, Matthew J Hepburn, et al.
NPJ Vaccines|January 28, 2022
Restricted valency (NPNA)<sub>n</sub> repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparumMark D Langowski, Farhat A Khan, Sofya Savransky, et al.
Plos One|June 3, 2021
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platformSidhartha Chaudhury, Jack Hutter, Jessica S Bolton, et al.
The Journal of Infectious Diseases|August 19, 2025
Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protectionDeAnna J Friedman-Klabanoff, Travis L Jensen, Casey E Gelber, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trialMichael W Ellis, Matthew E Griffith, David P Dooley, et al.
Vaccine|October 1, 2021
A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01<sub>E</sub> in a controlled human malaria infection challengeJames E Moon, Melissa E Greenleaf, Jason A Regules, et al.
The Journal of Infectious Diseases|July 21, 2020
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive AdultsJames E Moon, Christian Ockenhouse, Jason A Regules, et al.
Pageof 3